Organon & Co. (OGN)
$13.81+0.44%Close
BUYBULL · day 112
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3.6B
- Beta
- 1.52
- Div yield
- 0.58%
- P/E (TTM)
- 17.39
- Short % float
- 7.26%
- Days to cover
- 9.1
- SI change
- +8.2%
- 1W
- +0.66%
- 1M
- +1.32%
- vs SPY 1W
- -0.50%
- vs SPY 1M
- -1.67%
Industry peers
FMP comparable companies · ranked by market cap
- GRDNSELLGuardian Pharmacy Services, Inc.$2.7BBEARQ 59$42.10-0.77%
- HRMYSELLHarmony Biosciences Holdings, Inc.$2.3BBEARQ 1$39.92+1.72%
- MDSELLPediatrix Medical Group, Inc.$2.1BBULLQ 15$26.10+1.52%
- AVDLAvadel Pharmaceuticals plc$2.1B$21.64
- ALVOBUYAlvotech$2.1BRECOVERYQ -3$6.11+1.94%
- SEMSelect Medical Holdings Corporation$2.0B$16.51
- AUPHSELLAurinia Pharmaceuticals Inc.$2.0BBEARQ 22$15.72+2.65%
- NUVBSELLNuvation Bio Inc.$1.7BCRISISQ 4$4.95+1.01%
- PAHCBUYPhibro Animal Health Corporation$1.5BRECOVERYQ 10$37.19+2.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on OGN?
- LOPJLB’s latest quantitative signal on Organon & Co. (OGN) is BUY in a BULL regime. Signals are updated daily.
- What market regime is OGN in?
- Organon & Co. (OGN) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Organon & Co. (OGN) do?
- Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collection includes three immune-related medications (Br…